Literature DB >> 24695835

Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests.

Jeng-Yih Wu1, Sophie S W Wang1, Yi-Chern Lee1, Yoshio Yamaoka1, David Y Graham1, Chang-Ming Jan1, Wen-Ming Wang1, Deng-Chyang Wu1.   

Abstract

AIM: To evaluate the utility of the string test to detect genotypic clarithromycin-resistant Helicobacter pylori (H. pylori) by polymerase chain reaction (PCR)-restriction fragment length polymorphism.
METHODS: Patients undergoing endoscopic examinations were enrolled in the present study. String tests were done on the next day of endoscopy. Segments of 23S rRNA were amplified from DNA obtained from string tests. PCR-restriction fragment length polymorphism was accomplished by restriction enzymes BbsI and BsaI recognizing the mutation site A to G at 2143 or at 2142 of 23S rRNA domain V, respectively.
RESULTS: One hundred and thirty-four patients with H. pylori infection underwent string tests. To compare phenotypic resistance, 43 isolates were successfully cultured in 79 patients in whom 23S rRNA was successfully amplified. Of five patients with clarithromycin-resistant H. pylori, 23S rRNA of H. pylori isolates from four patients could be digested by BsaI. In 38 susceptible isolates, 23S rRNA of H. pylori isolates from 36 patients could not be digested by either BsaI or BbsI. The sensitivity and specificity of the string test to detect genotypic clarithromycin resistance were 66.7% and 97.3%, respectively. Positive and negative predictive values were 80% and 94.7%, respectively.
CONCLUSION: String test with molecular analysis is a less invasive method to detect genotypic resistance before treatment. Further large-scale investigations are necessary to confirm our results.

Entities:  

Keywords:  Clarithromycin resistance; Helicobacter pylori; Polymerase chain reaction-restriction fragment length polymorphism; String test

Mesh:

Substances:

Year:  2014        PMID: 24695835      PMCID: PMC3964405          DOI: 10.3748/wjg.v20.i12.3343

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.

Authors:  Jyh-Ming Liou; Chi-Yang Chang; Wang-Huei Sheng; Yu-Chi Wang; Mei-Jyh Chen; Yi-Chia Lee; Hsu-Wei Hung; Hung Chian; San-Chun Chang; Ming-Shiang Wu; Jaw-Town Lin
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  Estimates of Helicobacter pylori densities in the gastric mucus layer by PCR, histologic examination, and CLOtest.

Authors:  J A Nowak; B Forouzandeh; J A Nowak
Journal:  Am J Clin Pathol       Date:  1997-09       Impact factor: 2.493

Review 3.  Pathophysiology of antibiotic resistance: clarithromycin.

Authors:  D E Taylor
Journal:  Can J Gastroenterol       Date:  2000-11       Impact factor: 3.522

4.  Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries.

Authors:  Y Yamaoka; M S Osato; A R Sepulveda; O Gutierrez; N Figura; J G Kim; T Kodama; K Kashima; D Y Graham
Journal:  Epidemiol Infect       Date:  2000-02       Impact factor: 2.451

5.  Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes.

Authors:  Jeng Yih Wu; Jae J Kim; Rita Reddy; W M Wang; David Y Graham; Dong H Kwon
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

7.  Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan.

Authors:  Emiko Rimbara; Norihisa Noguchi; Hidenobu Kijima; Tai Yamaguchi; Takashi Kawai; Masanori Sasatsu
Journal:  Int J Antimicrob Agents       Date:  2007-06-21       Impact factor: 5.283

8.  DNA-level diversity and relatedness of Helicobacter pylori strains in shantytown families in Peru and transmission in a developing-country setting.

Authors:  Phabiola M Herrera; Melissa Mendez; Billie Velapatiño; Billie Velapatiõ; Livia Santivañez; Livia Santivaez; Jacqueline Balqui; S Alison Finger; Jonathan Sherman; Mirko Zimic; Lilia Cabrera; Jose Watanabe; Carlos Rodríguez; Robert H Gilman; Douglas E Berg
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

9.  Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.

Authors:  David Y Graham; Yi-Chia Lee; Ming-Shiang Wu
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-08       Impact factor: 11.382

10.  Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki; Masayuki Suzuki; Masahiko Takahashi; Toshifumi Hibi
Journal:  J Clin Biochem Nutr       Date:  2012-03-30       Impact factor: 3.114

View more
  3 in total

Review 1.  Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki
Journal:  Front Mol Biosci       Date:  2014-10-24

2.  Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection.

Authors:  David Espinosa-Ramos; Diana Caballero-Hernández; Ricardo Gomez-Flores; Armando Trejo-Chávez; Luis Jerónimo Pérez-Limón; Myriam Angélica de la Garza-Ramos; Reyes Tamez-Guerra; Patricia Tamez-Guerra; Cristina Rodriguez-Padilla
Journal:  Can J Infect Dis Med Microbiol       Date:  2019-04-01       Impact factor: 2.471

3.  A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice.

Authors:  Chao-Hung Kuo; Chung-Jung Liu; Ching-Chia Yang; Fu-Chen Kuo; Huang-Ming Hu; Hsiang-Yao Shih; Meng-Chieh Wu; Yen-Hsu Chen; Hui-Min David Wang; Jian-Lin Ren; Deng-Chyang Wu; Lin-Li Chang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.